Forte Biosciences, Inc. S-3 May. 28, 2021 16:06


2.2.5. the rate (s) (which may be fixed or variable) per year or, if applicable, the method used to determine such rate (s) (including, but not limited to, any commodity, commodity index, index market or financial index) on which the Series Notes will bear interest, if applicable, the date or dates from which such interest, if any, will accrue, the date or dates on which such interest, if applicable, begin and be payable and any regular registration date for interest payable on any interest payment date;

2.2.6. the place or places where the principal and interest, if any, of the Notes of the Series will be payable, where the Notes of this Series may be delivered for registration of the transfer or exchange and where notices and requests addressed to or on the Company in the securities of this series and this Deed of Trust may be delivered, together with the method of payment, by bank transfer, courier or otherwise;

2.2.7. if applicable, the period (s) during which, the price (s) at which and the terms and conditions under which the Series Notes may be redeemed, in whole or in part, at the option of the Company;

2.2.8. the obligation, if any, of the company to redeem or purchase the securities of the series in accordance with a sinking fund or similar provisions or at the option of a holder thereof and the period (s) during which, the price or prices at which the terms and conditions under which the Series Securities will be redeemed or purchased, in whole or in part, in accordance with this obligation;

2.2.9. the dates, if any, on which and the price or prices at which the securities of the series will be redeemed by the Company at the option of their holders and other detailed terms and provisions of such redemption obligations;

2.2.10. if it is not in denominations of $ 1,000 and any whole multiple thereof, the denominations in which the securities of the series may be issued;

2.2.11. the forms of the Notes in the Series and whether the Notes may be issued as global Notes;

2.2.12. if it is different from the principal amount thereof, the part of the principal amount of the Notes of the Series which will be payable upon the declaration of acceleration of the maturity thereof in accordance with Section 6.2;

2.2.13. the currency of denomination of the securities in the series, which may be the dollar or any foreign currency, and if this denomination currency is a composite currency, the agency or organization, if applicable, responsible for overseeing this composite currency;

2.2.14. the designation of the currency, currencies or currency units in which payment of principal and interest, if any, on the Series Notes will be made;

2.2.15. whether payments of principal or interest, if any, on the Series Securities are to be made in one or more currencies or monetary units other than that or those in which such Securities are denominated, the manner in which the exchange rate at these payments will be determined;

2.2.16. how the principal or interest payment amounts, if any, on the securities of the series will be determined, if such amounts can be determined by reference to an index based on

-6-

Previous Letters to the Editor | The Economist
Next Renminbi Blockbuster Week Gets Attention From PBOC, Business News & Top Stories